Written by  Joseph Santiago

These Were Voted the Best Psychedelics for a First-Time Journey

Silhouette of a person in a calm meditative posture against a cosmic background, symbolizing a first-time psychedelic journey and harm reduction
A visual representation of a first-time psychedelic journey, emphasizing calm preparation, reflection, and harm reduction.

Harm Reduction Insights from 581 Experienced Users

As interest in psychedelics grows, a record number of people are considering their first psychedelic experience — often outside clinical or medical settings.

But psychedelics are powerful tools. For beginners, the choice of substance matters far more than many people realise.

Rather than relying on hype, anecdotes, or influencer opinions, a 2025 peer-reviewed study published in the Harm Reduction Journal asked a simple but critical question:

Which psychedelics actually help first-timers have safer, more successful experiences in the real world?

To answer this, researchers surveyed 581 people with lived psychedelic experience, including everyday users, sitters, guides, therapists, educators, healthcare providers, and researchers.

What emerged is one of the clearest, community-informed harm-reduction resources available today.

This article focuses first — deliberately — on what the psychedelic community itself voted as the best (and worst) options for a first-time journey, and why.

Key Findings from the Study

  • 🥇 Psilocybin was the clear #1 recommendation for first-time experiences
  • ⚠️ Cannabis and MDMA were conditionally recommended, depending on the person
  • 🚫 Ayahuasca, DMT, 5-MeO-DMT, and Salvia were strongly discouraged for beginners
  • Safer experiences depend more on dose, preparation, and environment than the substance alone
  • First-timers use the fewest harm-reduction practices — exactly when they need them most

About the Study (Why This Matters)

Study title:
Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community

Published in: Harm Reduction Journal (2025)
Institutions: University of Michigan & University at Buffalo
Participants: 581 people with real-world psychedelic experience

This study used community-based participatory research, meaning members of the psychedelic community helped design the questions and interpret the findings.

Participants were asked:

  • Which psychedelics they would recommend for a first experience
  • Which they would not recommend
  • Why they felt that way
  • What advice they would give first-time users

The results reflect lived experience, not theory.

🏆 Psychedelics Voted Best for a First-Time Journey

🥇 #1 — Psilocybin (Magic Mushrooms or Truffles)

Psilocybin was by far the most recommended substance, endorsed by nearly 74% of participants.

This included people who had experience with many different psychedelics.

Why psilocybin ranked highest:

  • Moderate intensity compared to other psychedelics
  • Clear, dose-dependent effects (easy to start low)
  • Predictable trajectory
  • Relatively shorter duration than LSD or ayahuasca
  • Extensive scientific, cultural, and historical knowledge
  • Lower physiological toxicity compared to many legal substances

Only 2.6% of participants advised against psilocybin for first-time use — an unusually low number compared to other substances.

Many respondents described psilocybin as:

  • “Forgiving”
  • “Educational”
  • “A good teacher without being overwhelming”
🥈 Cannabis (Conditionally Recommended)

About 48% of participants recommended cannabis as a possible first psychedelic-adjacent experience.

Why it ranked relatively high:

  • Familiarity for many users
  • Shorter duration
  • Easier to stop if uncomfortable

Important caveat:
Cannabis was often recommended with caution. Participants noted that it can:

  • Amplify anxiety
  • Feel unpredictable
  • Affect people very differently

Cannabis was seen as accessible, but not universally gentle.

🥉 MDMA / MDA (Ecstasy, Molly)

Roughly 30% of participants recommended MDMA or MDA.

Why:

  • Strong empathogenic and prosocial effects
  • Less perceptual distortion than classic psychedelics
  • Often emotionally supportive rather than destabilising

Many respondents felt MDMA can be psychologically easier for some first-timers, though it is pharmacologically distinct from classic psychedelics like psilocybin.

🚫 Psychedelics NOT Recommended for a First Experience

Participants were equally clear about which substances beginners should generally avoid.

Most Frequently Discouraged:

❌ Ayahuasca
❌ DMT
❌ 5-MeO-DMT
❌ Salvia divinorum
❌ High-dose LSD

Why these ranked lowest:

  • Extremely high intensity
  • Rapid onset or very long duration
  • Greater likelihood of panic or disorientation
  • Increased mental health risks without experienced guidance

Key insight: Participants who had personally used these substances were more likely — not less — to advise beginners against them.

Visual Summary: How Substances Ranked for First-Timers

Substance% RecommendedBeginner Suitability
Psilocybin~74%⭐⭐⭐⭐⭐
Cannabis~48%⭐⭐⭐
MDMA/MDA~30%⭐⭐⭐
LSD~18%⭐⭐
Ayahuasca~3%🚫
DMT~3%🚫
5-MeO-DMT~1%🚫
Salvia<1%🚫

Why LSD Ranked Lower (Clarification)

LSD was not universally rejected, but concerns included:

  • Long duration (8–12+ hours)
  • Harder dose control
  • Greater physical and mental exhaustion for beginners

Many participants noted LSD can be meaningful — just not ideal as a first step.

What Actually Makes a Psychedelic “Beginner-Friendly”?

Across substances, participants consistently prioritised:

  • Moderate, controllable intensity
  • Predictable dose-response
  • Manageable duration
  • Lower likelihood of overwhelming psychological effects
  • Established knowledge base

Pull-quote:
“Intensity doesn’t equal insight — preparation does.”

Beyond the Substance: The Missing Piece

One of the most important findings wasn’t about which psychedelic to choose — but how first-timers prepare.

The study found:

  • First-timers use fewer harm-reduction practices than experienced users
  • Poor preparation strongly correlates with difficult experiences
  • Mindset and environment often matter more than the substance itself

Core Harm-Reduction Advice from the Psychedelic Community

Mental Preparation
  • Learn about the substance beforehand
  • Set a gentle intention, not rigid expectations
  • Accept uncertainty
  • Remember: whatever arises will pass
Environment (Set & Setting)
  • Be with people you trust
  • Choose a safe, familiar space
  • Avoid chaotic or high-pressure environments
  • Ideally have a sober or experienced sitter
Practical Wisdom
  • Start with a low dose
  • Avoid mixing substances (especially alcohol)
  • Allow time afterward for rest and reflection

Important Mental Health Considerations

Psychedelics may not be appropriate for individuals with:

  • A personal or family history of psychosis
  • Bipolar I disorder
  • Severe untreated anxiety or panic disorder

This is not moral judgement — it is risk awareness.

Why This Research Is Different

  • Peer-reviewed and open-access
  • Based on 581 lived experiences, not theory
  • Includes therapists, guides, and healthcare providers
  • Uses community-based participatory research

This combination is rare in psychedelic literature.

Gentle Closing Reflection

Psychedelics aren’t about spectacle or bravado.

For first-timers, the safest path forward is often the simplest one:
start small, stay informed, and respect the experience.

Optional Resources for Readers Who Want to Learn More

These resources are not required to understand the research discussed above. They are included for readers who wish to explore psychedelics further through education, harm reduction, and scientific context, at their own pace.

Independent Education, Research & Harm Reduction

  • Harm Reduction Journal (Open-Access Research)
    https://harmreductionjournal.biomedcentral.com/
    Peer-reviewed research on drug use, safety, and harm reduction, including the study referenced in this article.
  • MAPS – Multidisciplinary Association for Psychedelic Studies
    https://maps.org/
    One of the world’s leading organizations researching the therapeutic use of psychedelics and MDMA.
  • Johns Hopkins Center for Psychedelic and Consciousness Research
    https://hopkinspsychedelic.org/
    A major academic research center studying psilocybin and mental health in clinical settings.
  • Imperial College London – Centre for Psychedelic Research
    https://www.imperial.ac.uk/psychedelic-research-centre/
    Known for cutting-edge research on psychedelics, brain imaging, and consciousness.
  • Erowid
    https://www.erowid.org/
    A long-standing, neutral drug education library documenting effects, risks, and experiences.
  • The Zendo Project
    https://zendoproject.org/
    A harm-reduction organization offering peer-based support for challenging psychedelic experiences.
  • Fireside Project (Psychedelic Peer Support Line)
    https://firesideproject.org/
    Free, confidential emotional support during or after psychedelic experiences.
  • DoubleBlind Magazine
    https://doubleblindmag.com/
    Editorial coverage of psychedelics, harm reduction, integration, and cultural context.

Practical Guides & Educational Resources (Microdose Bros)

For readers looking for structured, beginner-friendly education and practical guidance, the following resources may be helpful:

References

  • Kruger et al. (2025). Best practices for first psychedelic experiences. Harm Reduction Journal
    https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-025-01337-2
  • Johnson et al. (2008). Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology
  • Palmer & Maynard (2022). Are you tripping comfortably? Harm Reduction Journal
  • Nichols (2016). Psychedelics. Pharmacological Reviews